CAVALETTI, GUIDO ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 49.098
EU - Europa 23.794
AS - Asia 14.435
SA - Sud America 722
OC - Oceania 115
AF - Africa 98
Continente sconosciuto - Info sul continente non disponibili 60
Totale 88.322
Nazione #
US - Stati Uniti d'America 48.172
SG - Singapore 5.656
IT - Italia 4.719
CN - Cina 4.272
DE - Germania 3.873
SE - Svezia 3.264
IE - Irlanda 3.170
RU - Federazione Russa 2.525
UA - Ucraina 2.433
HK - Hong Kong 2.196
GB - Regno Unito 1.120
CA - Canada 869
FI - Finlandia 659
BR - Brasile 615
AT - Austria 543
VN - Vietnam 494
FR - Francia 402
ID - Indonesia 387
IN - India 361
DK - Danimarca 270
NL - Olanda 253
TR - Turchia 222
JP - Giappone 211
KR - Corea 189
BE - Belgio 139
AU - Australia 92
IR - Iran 81
PL - Polonia 70
ES - Italia 61
TW - Taiwan 55
EU - Europa 53
PK - Pakistan 39
CZ - Repubblica Ceca 38
MY - Malesia 38
CH - Svizzera 34
PT - Portogallo 34
MX - Messico 32
RO - Romania 31
IL - Israele 30
EG - Egitto 26
AR - Argentina 25
UZ - Uzbekistan 25
GR - Grecia 24
EC - Ecuador 23
IQ - Iraq 23
NZ - Nuova Zelanda 23
ZA - Sudafrica 21
HR - Croazia 20
PH - Filippine 19
BD - Bangladesh 18
NO - Norvegia 17
PE - Perù 16
SA - Arabia Saudita 15
BG - Bulgaria 14
CL - Cile 14
KG - Kirghizistan 14
AE - Emirati Arabi Uniti 13
MA - Marocco 13
TH - Thailandia 13
RS - Serbia 12
SC - Seychelles 10
AL - Albania 9
CO - Colombia 9
JO - Giordania 9
AZ - Azerbaigian 8
HU - Ungheria 8
LV - Lettonia 8
MD - Moldavia 8
VE - Venezuela 8
KZ - Kazakistan 7
LT - Lituania 7
LU - Lussemburgo 7
GT - Guatemala 6
PY - Paraguay 6
TN - Tunisia 6
LB - Libano 5
PA - Panama 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BH - Bahrain 4
BO - Bolivia 4
BY - Bielorussia 4
CR - Costa Rica 4
DZ - Algeria 4
JM - Giamaica 4
MT - Malta 4
MU - Mauritius 4
OM - Oman 4
A1 - Anonimo 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GE - Georgia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
AO - Angola 2
BN - Brunei Darussalam 2
ET - Etiopia 2
KE - Kenya 2
Totale 88.296
Città #
Ann Arbor 9.449
Woodbridge 4.641
Singapore 3.638
Fairfield 3.560
Houston 3.434
Dublin 3.075
Chandler 2.845
Jacksonville 2.527
Frankfurt am Main 2.298
Wilmington 2.277
Ashburn 2.194
Hong Kong 2.141
Dearborn 1.763
Milan 1.499
Seattle 1.385
Princeton 1.244
New York 1.236
Santa Clara 1.187
Cambridge 1.184
Nanjing 720
Boardman 578
Shanghai 504
Vienna 466
Lawrence 459
Altamura 450
Hangzhou 450
Beijing 426
Lachine 413
Jakarta 356
Guangzhou 260
Dong Ket 256
Council Bluffs 237
Nanchang 219
Helsinki 205
Andover 204
San Diego 202
Toronto 201
Shenyang 195
Rome 172
Hebei 154
Falls Church 134
Los Angeles 128
Tianjin 123
Chicago 120
Nuremberg 120
Ottawa 119
Changsha 116
Fremont 116
Jiaxing 116
Brussels 113
Grafing 112
Kazan 112
Jinan 110
Mountain View 100
London 92
Norwalk 88
Huizen 85
Pune 85
Detroit 79
Kunming 75
Carate Brianza 74
Ningbo 71
Zhengzhou 67
Nürnberg 58
Melzo 57
Hefei 55
Dallas 53
Florence 53
Tokyo 52
Edmonton 50
São Paulo 49
Washington 48
San Mateo 47
Munich 44
Redmond 43
Leawood 38
Daejeon 37
Turin 37
Lissone 34
Sydney 34
Bergamo 32
Paris 32
Phoenix 32
Taizhou 32
Philadelphia 31
Sacramento 31
Bologna 30
Kiev 29
Naples 29
Auburn Hills 28
Bari 27
Saint Petersburg 27
University Park 27
Brno 26
Lappeenranta 26
Romola 26
Catania 25
Rio de Janeiro 25
Kocaeli 24
Mainz 24
Totale 62.411
Nome #
La citofluorimetria a flusso nella caratterizzazione immunofenotipica dei linfociti in corso di Encefalite Autoimmune Sperimentale. 524
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 421
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 407
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 372
Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment 362
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 339
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 334
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 322
Malattie del Sistema Nervoso 321
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 316
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 315
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 312
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 309
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 309
Age-related changes in the function and structure of the peripheral sensory pathway in mice 305
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 302
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 300
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 298
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 293
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 290
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 283
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 282
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 276
The Italian multiple sclerosis register 274
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 274
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 273
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 261
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 260
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 257
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 256
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 256
Enhanced brain targeting of engineered solid lipid nanoparticles 255
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 249
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 247
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 242
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 241
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 241
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 240
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 238
Malattie del Sistema Nervoso 235
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 235
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 233
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 225
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 225
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease 224
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 223
Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y 223
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 223
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 223
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 222
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 221
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 221
Are sigma receptor modulators a weapon against multiple sclerosis disease? 220
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 219
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 218
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 215
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 214
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 214
Role of MAPKs in platinum-induced neuronal apoptosis 213
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 211
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 210
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 208
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 204
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 204
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 203
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 203
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 203
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline 201
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 201
An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy 197
Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis 196
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 196
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 194
Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells 193
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 193
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 192
Pain in chemotherapy-induced peripheral neurotoxicity 192
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 191
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer 191
NCI Clinical Trials Planning Meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy 191
Histological features of nerve fibers and endoneural vessels in a case of Wegener's granulomatosis. 190
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 190
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 190
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 189
Hemorrhagic infarction: risk factors, clinical and tomographic features, and outcome. A case-control study 189
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 189
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 189
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 189
The Italian neuromuscular registry: A coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage 188
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools 187
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients 186
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 185
A clinico-pathological and follow up study of 10 cases of essential type II cryoglobulinaemic neuropathy 185
Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases 185
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 185
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 185
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study 184
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 183
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 183
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 183
Totale 24.010
Categoria #
all - tutte 339.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 339.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.079 0 0 0 0 0 0 0 0 0 900 898 281
2020/202111.730 705 487 1.422 1.222 840 908 1.351 1.075 1.006 1.072 606 1.036
2021/20227.268 464 759 732 672 492 676 355 400 350 499 561 1.308
2022/202312.644 1.552 3.530 1.184 1.077 893 1.970 170 657 896 141 314 260
2023/202410.575 335 389 450 424 1.434 2.369 1.959 439 786 247 246 1.497
2024/202515.832 1.585 2.872 1.748 1.200 2.163 931 1.391 976 2.945 21 0 0
Totale 92.339